World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON, MA, ELMWOOD PARK, NJ, and Rolle, Switzerland, November 7, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that […]
Search Results for: log in
26
Oct
Oct
According to the National Down syndrome Society, in the US, 1 in 772 live births result in a Down syndrome diagnosis, making Down syndrome the most common chromosomal condition. The month of October is Down Syndrome Awareness Month, giving families, individuals, and patients the opportunity to share information about the condition, learn more, and contribute […]
09
May
May
National Women’s Health Week is an annual initiative driven by the U.S. Department of Health and Human Services that aims to raise awareness and encourage women to make their health a priority. While finding the time and resources to properly manage one’s health may feel overwhelming, there are many actionable ways women can take to […]
14
Apr
Apr
No matter age or background, there are about 20 million new sexually transmitted infection cases every year in the US, according to ASHA. Anyone that is sexually active can become infected with a sexually transmitted infection or STI, according to the CDC. However, there are some groups that are more affected: adolescents, young adults, pregnant […]
27
Mar
Mar
Colorectal cancer is the third most common cancer diagnosed in both men and women each year in the United States, excluding skin cancer. About 1 in 25 people in the U.S. will develop colorectal cancer during their lifetime, according to the American Cancer Society; however, with regular screening, it can be detected early.1 What is […]
Press Release
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
09
Feb
Feb
CINtec® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, NJ, February 9, 2023 – BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from […]
17
Nov
Nov
You might have noticed an update in our name from BioReference Laboratories, Inc. to BioReference Health, LLC. While it may be a small shift in what we call ourselves, our new identity represents a significant difference in how we deliver our solutions and services. For more than four decades, BioReference has built a legacy based […]
LabPulse.com Aspira Women’s Health on Wednesday announced a collaboration for ovarian cancer testing with Opko Health’s BioReference Laboratories. The firms will co-market and distribute Aspira’s Ova1Plus, which combines its U.S. Food and Drug Administration-cleared blood tests, Ova1 and Overa, to detect the risk of ovarian malignancy in women with adnexal masses prior to surgery. Under the […]
Press Release
Aspira Women’s Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference
05
Oct
Oct
Aspira Women’s Health Inc. OVA1Plus® now available to an expanded network of physicians, supporting patients nationwide AUSTIN, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the formal launch of its co-marketing and distribution collaboration with BioReference®, an OPKO Health […]
25
Aug
Aug
Spinal muscular atrophy (SMA) affects 1 per 8,000 to 10,000 people around the world, according to the National Library of Medicine.1 For SMA Awareness Month, we’re bringing attention to this genetic disorder by highlighting information about how the disease is inherited and the options for SMA testing during pregnancy or preconception. What Is SMA? Spinal […]
